Should I buy Gentex (GNTX) stock or is it too late?

Gentex · Consumer Discretionary · price $21

⭐ What the most reliable analysts say · those who beat their sector, targets replayed on real prices

⭐ The most reliable of them, either direction: UBS — 61% of its targets hit on this sector (220 calls tested). It aims for $24 (+15 %), call made on October 8, 2026, maturing on October 8, 2027 (6 d ago).

The 1 reliable analyst $24+15 %

The 4 other firms $26.50+27 %

How to read it: the 1 reliable firms are not filtered by optimism — 1 aim above the price, 0 below, hence their $24 median. “The 4 others” are the firms that don't pass our reliability filter on this sector.

Firm-by-firm track record on Gentex

Here the hit rate is measured <b>on this stock specifically</b> (matured targets replayed against real prices, minimum 5 calls tested) — the green block above measures reliability <b>across the whole sector</b>, which is the criterion behind JPI selections. “Aims for” = the firm's most recent target on this stock; “—” means it hasn't published one recently.

Firm	% right	Gain vs sector	Calls	Aims for
Baird	43 %	-5.5 %	7	$26 +25%
Goldman Sachs	60 %	-7.1 %	5	$20 -4%
B. Riley Securities	25 %	-9.4 %	8	$29 +39%
Guggenheim	20 %	-18.4 %	5	$24 +15%
Keybanc	50 %	+3.3 %	6	—

In short — Should you invest in Gentex? Is it too late, still worth it? Analysts are split (20% buy, median target $26, i.e. +25%), and the most reliable on GNTX targets even higher. But the stock is volatile. We give you both sides, with the numbers — not advice.

✅ Reasons to believe

Median price target $26, i.e. +25% from the current price ($21).
The most reliable firm on GNTX, JP Morgan (100% hit rate, 2 scored calls), targets $27 (call made on August 10, 2026, maturing on August 10, 2027) (+29%) in its most recent call, and $32 (call made on October 20, 2025, maturing on October 20, 2026) (+53%) in the one coming due soonest.
Pays a dividend (1.9% yield) — regular income on top of potential upside.

⚠️ Reasons to hesitate

The consensus is not unanimous: of 5 ratings, 3 are neutral and 1 is a sell.
A 12-month target is not a guaranteed path: the price can fall in the meantime.
Volatile stock: sharp swings — including steep drops — are part of its profile.

The analyst consensus on GNTX

Median target $26 (+25%) · 5 ratings · Hold consensus

Strong Buy00%

Buy120%

Hold360%

Sell120%

Strong Sell00%

⚠️ Information, not investment advice. Past performance does not guarantee future results. Analyst targets on a ~12-month horizon.

Frequently asked questions

Should you invest in Gentex now?

We won't decide for you. The facts: 20% of analysts rate it a buy, median target $26 (+25%), and JP Morgan (most reliable on GNTX, 100%) targets $27. Weigh that against valuation and volatility. This is not personalized advice.

Is it too late to invest in Gentex?

Not according to analysts: the median target ($26) is still +25% above the current price ($21) (most reliable on GNTX: JP Morgan, 100%). The real question isn't "too late" but the price-to-value gap and risk. Not advice.

Is Gentex still worth investing in?

It depends on the gap between the price ($21) and its estimated value: analysts target $26 on median (+25%), with 20% buys (most reliable on GNTX: JP Morgan, 100%). Cross-check with their real reliability on GNTX and the cautions above. Information, not advice.

What's the main risk in buying GNTX?

The consensus is not unanimous: of 5 ratings, 3 are neutral and 1 is a sell.

→ Go deeper: the full Gentex profile (consensus, analyst reliability, price target, performance).